PROKIDNEY CORP (PROK)

KYG7S53R1049 - Common Stock

1.51  +0.05 (+3.42%)

After market: 1.6238 +0.11 (+7.54%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/AN/A
189.43%
N/A
60.19%
N/A
44.35%
N/A
31.56%
EBITDA
YoY % growth
-26.06M-53.13M
-103.88%
-149.97M
-182.27%
-147.669M
1.53%
N/A
-10.88%
N/A
-13.58%
N/A
-12.77%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-27.02M-55.11M
-103.96%
-153.01M
-177.64%
-151.522M
0.97%
N/A
-20.06%
N/A
-10.23%
N/A
-2.01%
N/A
-22.03%
N/A
62.70%
N/A
85.46%
N/A
771.17%
N/A
120.18%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A-0.57
51.54%
N/A
-4.80%
N/A
24.25%
N/A
-71.52%
N/A
-16.95%
N/A
64.04%
N/A
31.25%
N/A
86.36%
N/A
566.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.15
-67.96%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-49.007M
-140.74%
EBIT
Q2Q % growth
-48.077M
-98.58%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.14
22.22%
-0.150.015.99%
Q2 2024
Q2Q % growth
-0.16
-14.29%
-0.170.018.40%
Q1 2024
Q2Q % growth
-0.16 -0.180.0212.37%
Q4 2023
Q2Q % growth
-0.09
18.18%
-0.170.0848.25%
Q3 2023
Q2Q % growth
-0.18
-38.46%
-0.16-0.02-11.83%
Q2 2023
Q2Q % growth
-0.14 -0.400.2665.12%
Q1 2023
Q2Q % growth
-0.16 -0.400.2459.93%
Q4 2022
Q2Q % growth
-0.11 -0.250.1456.02%
Q3 2022
Q2Q % growth
-0.13 -0.240.1145.88%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-6.31% 8.14% -3.04% -13.21%
RevenueN/A N/A N/A N/A